Hyperparathyroidism is an increased parathyroid hormone (PTH) l... - dofaq.com
hyperparathyroidism

Hyperparathyroidism is an increased parathyroid hormone (PTH) l...

wikipedia - 19 Sep 2016
Hyperparathyroidism is an increased parathyroid hormone (PTH) levels in the blood. This occurs either from the parathyroid glands inappropriately making too much PTH (primary hyperparathyroidism) or other events triggering increased production by the parathyroid glands (secondary hyperparathyroidism). Most people with primary disease have no symptoms at the time of diagnosis. In those with symptoms the most common is kidney stones with other potential symptoms including weakness, depression, bone pai
hyperparathyroidism

Will Amgen (AMGN) Continue to Tread Growth Path This Year?

Nasdaq - 16 Jan 2018
While the FDA approved Mvasi - Amgen and Allergan's AGN biosimilar version of Roche's RHHBY cancer drug, Avastin - and Parsabiv for secondary hyperparathyroidism (sHPT), EU approved Amgevita, Amgen's biosimilar version of Humira,. Amgen also gained ...
hyperparathyroidism

Secondary Hyperparathyroidism Market Report from 2018 to 2025

satPRnews (press release) - 08 Jan 2018
Secondary Hyperparathyroidism Market report provides comprehensive insights of the ongoing therapeutic research and development across Secondary Hyperparathyroidism. The report provides a complete understanding of the Market activities covering all ...
hyperparathyroidism

EpiCast Report: Hyperparathyroidism – Epidemiology Forecast to 2025

satPRnews (press release) - 30 Dec 2017
The report “EpiCast Report: Hyperparathyroidism – Epidemiology Forecast to 2025” provide an overview of the risk factors and global trends of HPT in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological ...
hyperparathyroidism

Rockwell Medical (RMTI) Rating Lowered to Sell at BidaskClub ...

The Ledger Gazette - 21 Jan 2018
Rockwell Medical (NASDAQ:RMTI) was downgraded by research analysts at BidaskClub from a “hold” rating to a “sell” rating in a research note issued on Thursday. Separately, Zacks Investment Research cut shares of Rockwell Medical from a “hold” rating to ...
hyperparathyroidism

Endocrinology drug approvals from 2017

Healio - 02 Jan 2018
In a review of the 2017 milestones, Endocrine Today compiled a list of drugs related to the field that were newly approved, cleared and had label or indication changes. We put our best effort into making a complete list and regret any omission ...

What's New